Eli Lilly and Company (NYSE: LLY), a United States-based pharmaceutical company, announced on Monday its dividend for the second quarter of 2023.
The company has declared a dividend of USD1.13 per share on outstanding common stock.
The dividend will be paid to shareholders of record at 15 May 2023 on 9 June 2023.
Roquefort Therapeutics advances novel siRNA therapeutics
Perrigo Company announces quarterly dividend
Amgen announces Q3 2023 dividend
McKesson Corporation boosts quarterly dividend by 15% to USD0.62 per share